EXHIBIT 10.69 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT, dated as of March 31, 2003 between Talisman Management Limited ("Purchaser") and Viragen, Inc. (the "Company"). WHEREAS, simultaneously with the execution and delivery of...Registration Rights Agreement • May 14th, 2003 • Viragen Inc • Biological products, (no disgnostic substances) • New York
ARTICLE I DEFINITIONSSecurities Purchase Agreement • May 14th, 2003 • Viragen Inc • Biological products, (no disgnostic substances) • New York
VIRAGEN, INC.Viragen Inc • May 14th, 2003 • Biological products, (no disgnostic substances)
ARTICLE 1Common Stock Purchase Agreement • May 14th, 2003 • Viragen Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.72 NEITHER THESE SECURITIES NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM...Viragen Inc • May 14th, 2003 • Biological products, (no disgnostic substances)
EXHIBIT 10.74 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "AGREEMENT") is made and entered into as of April 16, 2003, among Viragen, Inc., a Delaware corporation (the "COMPANY"), and the purchasers signatory hereto (each...Registration Rights Agreement • May 14th, 2003 • Viragen Inc • Biological products, (no disgnostic substances) • New York
VIRAGEN, INC.Stock Purchase Agreement • May 14th, 2003 • Viragen Inc • Biological products, (no disgnostic substances)
EXHIBIT 10.67 Dear Mr. Smith: This letter is to confirm our mutual agreement with respect to the terms and conditions under which Gerald Smith and Associates, Inc. and Gerald Smith (individually) (together hereinafter known as "Consultant") agree to...Viragen Inc • May 14th, 2003 • Biological products, (no disgnostic substances)
EXHIBIT 10.75 ADDITIONAL FUNDING AGREEMENT This Agreement (this "AGREEMENT") is dated as of May 8, 2003, by and among Viragen, Inc. (the "COMPANY") and Palisades Equity Fund L.P., Crescent International Ltd. and Alpha Capital AG (collectively referred...Additional Funding Agreement • May 14th, 2003 • Viragen Inc • Biological products, (no disgnostic substances)
